Cecal Diseases: Clinical Trials

21 trials for Cecal Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 21 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 321Completed 15, Recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1
Phase 21Completed 1

Follow Cecal Diseases: new trials by email Literature Review of Cecal Diseases trials Research Report on Cecal Diseases

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis
Piperacillin/Tazobactam, Ceftriaxone + Metronidazole - Appendicitis Perforated, Appendectomy, Laparoscopic
Phase 3Not yet recruitingMcMaster Children's Hospital1802027-04-012026-10-09
Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma
Phase 3RecruitingCity of Hope Medical Center1292027-01-042026-11-05
Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain
Ketorolac Tromethamine, Morphine Sulfate, normal saline - Acute Pain, Abdomen, Acute
Phase 3RecruitingUniversity of Calgary4952024-05-272024-06-24
Comparison of Ketorolac at Three Doses in Children With Acute Pain
Ketorolac Tromethamine - Acute Pain, Abdominal Pain
Phase 3CompletedHamilton Health Sciences Corporation1712023-06-012025-07-09
Ketorolac for Moderate to Severe Abdominal Pain in Children
Ketorolac Tromethamine 10 MG/ML, Morphine Sulfate 10Mg/1mL Injection - Abdominal Pain, Appendicitis
Phase 3CompletedHamilton Health Sciences Corporation1052021-05-052023-02-28
Non-operative Treatment of Acute Non-perforated Appendicitis
Meronem and flagyl, Appendectomy - Acute Appendicitis
Phase 2 / Phase 3CompletedKing Edward Medical University1802018-09-012021-02-18
The Onset Time of Rocuronium in Emergency and Elective Surgery
Rocuronium elective surgery, Rocuronium emergency surgery, Propofol - Inguinal Hernia, Acute Appendicitis
Phase 3UnknownDiskapi Yildirim Beyazit Education and Research Hospital502015-12-012015-12-18
Feasibility of Outpatient Appendectomy for Acute Appendicitis
outpatient surgery - Acute Appendicitis
Phase 3CompletedCentre Hospitalier Universitaire, Amiens1202013-04-012025-09-22
Laparoscopic Appendectomy by Multi-port vs Single Port.
Single incision laparoscopic appendectomy, Multiport laparoscopic appendectomy - Acute Appendicitis
Phase 3UnknownAssociazione Chirurghi Ospedalieri Italiani3002013-03-012012-11-05
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Doripenem, Meropenem placebo, Meropenem - Abscess, Intra-Abdominal, Abdominal Abscess
Phase 3TerminatedJanssen Research & Development, LLC412010-12-012014-07-15
A Randomised Controlled Trial on LESS Versus Conventional Laparoscopic Appendicectomy.
LESS appendectomy, Conventional 3-port laparoscopic appendectomy - Appendicitis
Phase 3CompletedChinese University of Hong Kong2002009-10-012011-07-21
Single Incision Versus Conventional Laparoscopic Appendectomy
Single Incision Laparoscopic Appendectomy, Conventional appendectomy - Appendicitis
Phase 3CompletedHospital Universitario Virgen de la Arrixaca1842009-09-012012-01-24
Diagnosis of Acute Appendicitis: Low-dose Computed Tomography (CT) Versus Standard-dose CT
Diagnostic CT - Appendicitis
Phase 3CompletedSeoul National University Bundang Hospital8912009-09-012011-09-12
Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures
Metronidazole, Cefuroxime, Amoxicillin (+ clavulanic acid) and Fluconazole, Placebo - Acute Appendicitis, Perforated Gastroduodenal Ulcer
Phase 3CompletedThe Faculty Hospital Na Bulovce1872008-07-012012-02-08
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Early Versus Interval Appendectomy for Ruptured Appendicitis in Children
early appendectomy, interval appendectomy - Ruptured Appendicitis
Phase 3CompletedUniversity of Tennessee1282006-10-012010-01-12
Doripenem in the Treatment of Complicated Intra-Abdominal Infections
doripenem - Bacterial Infections and Mycoses, Appendicitis
Phase 3CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.4832004-03-012011-06-10
Doripenem in the Treatment of Complicated Intra-Abdominal Infections
Doripenem - Bacterial Infections and Mycoses, Appendicitis
Phase 3CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.4782004-03-012011-06-10
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
Cytoreductive surgery, Continuous hyperthermic peritoneal perfusion (HIPEC/CHPP) - Gastrointestinal Neoplasm
Phase 3CompletedNational Cancer Institute (NCI)302003-01-012012-11-22
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
dexamethasone, ondansetron, quality-of-life assessment - Cancer
Phase 3CompletedNCIC Clinical Trials Group2112001-02-282020-04-03

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Appendicitis (17)  ·  Abdominal Pain (5)  ·  Appendiceal Neoplasms (4)  ·  Peritonitis (3)  ·  Abdomen, Acute (2)  ·  Acute Pain (2)  ·  Bacterial Infections and Mycoses (2)  ·  Bile Duct Neoplasms (2)  ·  Carcinoma, Hepatocellular (2)  ·  Carcinoma, Ovarian Epithelial (2)  ·  Cholecystitis (2)  ·  Colonic Neoplasms (2)  ·  Emergencies (2)  ·  Gallbladder Neoplasms (2)  ·  Neoplasms (2)

Broader conditions

Digestive System Diseases (21)  ·  Gastrointestinal Diseases (21)  ·  Intestinal Diseases (21)  ·  Gastroenteritis (17)  ·  Infections (17)  ·  Intraabdominal Infections (17)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Signs and Symptoms (8)  ·  Neurologic Manifestations (6)  ·  Signs and Symptoms, Digestive (6)  ·  Pain (5)  ·  Biliary Tract Diseases (4)  ·  Cecal Neoplasms (4)  ·  Digestive System Neoplasms (4)

Interventions

Doripenem (3)  ·  Ketorolac Tromethamine (3)  ·  Metronidazole (3)  ·  Fentanyl (2)  ·  Meropenem (2)  ·  Morphine (2)  ·  Saline Solution (2)  ·  Ambulatory Surgical Procedures (1)  ·  Amoxicillin (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Appendectomy (1)  ·  Benchmarking (1)  ·  Bevacizumab (1)  ·  Biopsy (1)  ·  Ceftriaxone (1)

Sponsors

Hamilton Health Sciences Corporation (2)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Associazione Chirurghi Ospedalieri Italiani (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Chinese University of Hong Kong (1)  ·  City of Hope Medical Center (1)  ·  Diskapi Yildirim Beyazit Education and Research Hospital (1)  ·  Hospital Universitario Virgen de la Arrixaca (1)  ·  INSYS Therapeutics Inc (1)  ·  Janssen Research & Development, LLC (1)  ·  King Edward Medical University (1)  ·  Maxima Medical Center (1)  ·  McMaster Children's Hospital (1)  ·  NCIC Clinical Trials Group (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (5)  ·  Canada (4)  ·  Argentina (1)  ·  Brazil (1)  ·  Chile (1)  ·  China (1)  ·  Colombia (1)  ·  Czechia (1)  ·  France (1)  ·  Italy (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Pakistan (1)  ·  Panama (1)  ·  South Korea (1)

Top investigators

Mohamed Eltorki, MBChB (2)  ·  Anthony Y Teoh, FRCSEd (Gen) (1)  ·  Barbara Culbreath, RN (1)  ·  Ferdinando Agresta, MD (1)  ·  Kyoung Ho Lee, MD (1)  ·  Kyuseok Kim, MD (1)  ·  Larry Dillaha, MD (1)  ·  Luigi Boni, MD, FACS (1)  ·  Martin L Blakely, MD (1)  ·  Mustafa Raoof (1)  ·  Nereo Vettoretto, MD (1)  ·  Ondrej Ryska, MD (1)

Results publications

PMID 19670912, PMID 20211892, PMID 16849762, PMID 21339413, PMID 22480131, PMID 22533576, PMID 23154391, PMID 23386239, PMID 27020837, PMID 27437029, PMID 31096041, PMID 35383071, PMID 41066173

NIH funding

2009 (1), P30CA033572 (1)